|

Furosemide Injection Clinical Trials

2 actively recruiting trials

▼ -1 trial since May 2026

Also known as: 4-chloro-N-furfuryl-5-sulfamoylanthranilic acid

Pipeline

Phase 3: 1Phase 4: 1

Top Sponsors

  • University of Alberta1
  • Rigshospitalet, Denmark1

Indications

  • Acute Heart Failure1
  • Heart Disease1
  • Congestive Heart Failure1
  • Pulmonary Edema1
  • Lewy Body Disease1

Other2 trials

18F-DOPA II - PET Imaging Optimization
Phase 3
Optimized Treatment of Pulmonary Edema or Congestion
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.